Abstract
A novel function of polyarginine as an activator of the immune system is reported. Single‐molecule fluorescence imaging and single‐molecule force measurements demonstrate that polyarginine binds specifically to the toll‐like receptor 4 (TLR4), inducing receptor dimerization and activation. Moreover, polyarginine induced immune activation inhibits tumor growth. These results suggest the potential use of polyarginine for cancer immunotherapy.

This publication has 22 references indexed in Scilit: